Company Website

Contact Information:

Kate Olson
kolson@grailbio.com
715-377-2891

Jordan Stricker
jstricker@grailbio.com
303-902-4365

Kim Emery
kemery@grailbio.com
612-237-1602

Cynthia Hoffmann
choffmann@grailbio.com
651-399-2950

Virtual Exhibit Hall Home

GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. The company uses the power of next-generation DNA sequencing, population-scale clinical studies, and state-of-the-art computer and data science to overcome one of medicine’s greatest challenges. The first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings for adults with elevated risk of cancer. It detects a cancer signal across more than 50 types of cancer through a routine blood draw. When cancer is detected, the Galleri test can predict the cancer signal origin. For more information visit Galleri.com.

Additional Information:

Galleri Health Systems Brochure